Nureca Q4 FY26: Revenue Growth, Operating Turnaround, Investment-Led Loss
Ask Iris
Frequently Asked Questions
The presentation reports consolidated revenue from operations of 146.96 crore for FY26.
Q4 FY26 revenue from operations was reported at 35.4 crore and operating profit at 2.5 crore (7.2 percent margin).
The presentation states Q4 FY26 PAT was -6.1 crore due to fair value changes and net loss on investments recorded under other expenses as per Ind AS.
The presentation states more than 90 percent of revenue is generated through online sales.
The presentation highlights Dr Trust as the flagship brand and also references Dr Physio for product lines such as massagers.
Dr Trust 360 is a connected health app that syncs compatible devices into one platform. The presentation describes it as a freemium model with optional subscription for pro features like advanced reports and curated diet plans.
Through Nureca Technologies Pvt Limited, the presentation lists manufacturing of devices such as blood pressure monitors, nebulizers, massagers, thermometers, heating pads, orthopedic supports, and breast pumps, along with CDSCO approvals and ISO certifications.
Did your stocks survive the war?
See what broke. See what stood.
Live Q1 Earnings Tracker